Single-cell RNA-seq reveals disease-specific CD8+ T cell clonal expansion and a high frequency of transcriptionally distinct double-negative T cells in diabetic NOD mice
T cells primarily drive the autoimmune destruction of pancreatic beta cells in Type 1 diabetes (T1D). However, the profound yet uncharacterized diversity of the T cell populations in vivo has hindered obtaining a clear picture of the T cell changes that occur longitudinally during T1D onset. This study aimed to identify T cell clonal expansion and distinct transcriptomic signatures associated with T1D progression in Non-Obese Diabetic (NOD) mice. Here we profiled the transcriptome and T cell receptor (TCR) repertoire of T cells at single-cell resolution from longitudinally collected peripheral blood and pancreatic islets of NOD mice using single-cell RNA sequencing technology. We detected disease dependent development of infiltrating CD8 + T cells with altered cytotoxic and inflammatory effector states. In addition, we discovered a high frequency of transcriptionally distinct double negative (DN) T cells that fluctuate throughout T1D pathogenesis. This study identifies potential disease relevant TCR sequences and potential disease biomarkers that can be further characterized through future research.
Authors
- Jon A. Weidanz (ORCID: https://orcid.org/0000-0003-4455-9319)
- Jacob M. Luber (ORCID: https://orcid.org/0000-0001-5268-5732)
- Md Zohorul Islam (ORCID: https://orcid.org/0000-0002-2015-5195)
- Anders Lindahl (ORCID: https://orcid.org/0000-0003-2871-5166)
- Michael Robben (ORCID: https://orcid.org/0000-0002-5322-9947)
- Aleksandar D. Kostic (ORCID: https://orcid.org/0000-0002-0837-4360)
- José Ordovás-Montañés (ORCID: https://orcid.org/0000-0001-5444-5601)
- Sam Zimmerman
Institutions
- University of Copenhagen (DK)
- Boston Children's Hospital (US)
- Joslin Diabetes Center (US)
- Australian Centre for Disease Preparedness (AU)
- Harvard University (US)
- University of Illinois Urbana-Champaign (US)
- The University of Texas at Arlington (US)
- CSIRO Health and Biosecurity (AU)
- Harvard Stem Cell Institute (US)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-03-19
- DOI
- https://doi.org/10.1371/journal.pone.0317987
- Citations
- 2
- Primary Topic
- Diabetes and associated disorders
- Type
- article
- Field-Weighted Citation Impact
- 3.63
Funders
- Lundbeckfonden
- H. Lundbeck A/S